The relationship between peripheral T cell reactivity to insulin, clinical remissions and cytokine production in type 1 (insulin-dependent) diabetes mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 7, 1999, Pages 2419-2424

  Mayer, A ^a   Rharbaoui, F ^b   Thivolet, C ^a   Orgiazzi, J ^a   Madec, A M ^a  

^a INSERM   (France)

^b UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INSULIN;

ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETOGENESIS; FOLLOW UP; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033305760     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.7.2419     Document Type: Article

References (34)

1. Insulin-dependent diabetes mellitus as an autoimmune disease
2. Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicenter double-blind trial
3. Autoimmune polyendocrine failure-type 1 (insulin-dependent) diabetes mellitus and hypothyroidism-after allogeneic bone marrow transplantation in a patient with lymphoblastic leukaemia
4. Adoptive T cell transfer of autoimmune non-obese diabetic mouse diabetes does not require recruitment of host B lymphocytes
5. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice
6. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice
7. Two type of murine helper T cells. I. Definition according to profiles of lymphokine activities and secreted proteins
8. Immunoregulatory and cytokine imbalances in the pathogenesis of type 1 diabetic. Therapeutic intervention by immunostimulation?
9. Cellular immunity to human insulin in individuals at high risk for the development of type I diabetes mellitus
10. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes
11. Cellular immune response to diverse islet-cell antigens in type 1 diabetic
12. T-cell clones from a typed diabetes patient respond to insulin secretory granule proteins
13. Islet-reactive T-cells are a marker of preclinical insulin-dependent diabetes
14. Peripheral blood mononuclear cells of insulin-dependent diabetic patients respond to multiple islet cell proteins
15. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes
16. Glutamic acid decarboxylase 67-reactive T cells: A marker of insulin-dependent diabetes
17. Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects
18. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes
19. Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited
20. On the appearance of islet associated auto-immunity in offspring of diabetic mothers: A prospective study from birth
21. Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes
22. A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus
23. Cytokine-based human blood assay for the detection of antigen-reactive T cells
24. Systemic bias of cytokine production toward cell-mediated immune regulation in type 1 diabetic and toward humoral immunity in Graves' disease
25. Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type I (insulin-dependent) diabetes mellitus in high risk individuals
26. Type 1 diabetic and autoimmunity: Islet cell antibodies, insulin antibodies and β-cell failure
27. Nomenclature for factors of the HLA system
28. Reactivity to human islets and fetal pig proislets by peripheral blood mononuclear cells from subjects with preclinical and clinical insulin-dependent diabetes
29. IA-2 antibodies-a sensitive marker of IDDM with clinical onset in childhood and adolescence
30. HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus
31. The relationship between humoral and cellular immunity to IA-2 in IDDM
32. Pathways of processing of insulin by antigen-presenting cells
33. Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus
34. Extreme TH1 bias of invariant Vα24JαQ T cells in type 1 diabetes